← Back to Patent Explorer
US4046879A Expired / Lapsed US ⏱️ 0.0 years remaining

Antiviral compositions

Assignee: Boehringer Ingelheim GmbH
•
Filing: 1976-03-01
•
Granted: 1977-09-06
•
Expires: 1996-03-01
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A topical pharmaceutical antiviral composition consisting essentially of an inert pharmaceutical carrier or diluent, a complex-former for bivalent cations, and a 5'-triphosphate of a nucleoside or deoxyribonucleoside.

Inventors

  • 👤 Peter Swetly

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-01 14:16
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/70; A61K33/00; A61K33/42

Claims Analysis

Total Claims: 5
Claim 1
Independent Claim 49 words
A topical antiviral pharmaceutical composition consisting essentially of an inert carrier and uniformly distributed therein 0.05 to 20 mgm of at least one nucleoside triphosphate or deoxynucleoside triphosphate and 0.5 to 100 mgm of at least one complex-former for bivalent cations per gram of total weight of said composition.
Claim 2
Dependent Claim 49 words
A topical antiviral pharmaceutical composition consisting essentially of an inert carrier and uniformly distributed therein 0.05 to 20 mgm of at least one nucleoside triphosphate or deoxynucleoside triphosphate and 0.5 to 100 mgm of at least one complex-former for bivalent cations per gram of total weight of said composition.
Claim 3
Dependent Claim 37 words
An antiviral composition of claim 1, wherein said complex-former is sodium pyrophosphate, adenosine diphosphate, sodium citrate, ethylenediaminetetraacetic acid or pyridoxylamine, and said triphosphate is adenosine triphosphate, guanosine triphosphate, cytidine phosphate or the triphosphate of a corresponding deoxyribonucleoside.
Claim 4
Dependent Claim 18 words
An antiviral composition of claim 1, wherein said complex-former is sodium pyrophosphate and said triphosphate is adenosine triphosphate.
Claim 5
Dependent Claim 18 words
The method of combatting topical virus infections, which comprises treating the infection with a composition of claim 1.

References Cited (Backward Citations)

US3819830A Cited
US3948886A Cited
US3849553A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1980-09-05 1981-03-07 1981-09-06 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1984-09-05 1985-03-07 1985-09-06 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1988-09-05 1989-03-07 1989-09-06 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag